Last reviewed · How we verify
NCT03707652
Open-label Study to Assess Increasing Levels of NAD+(Nicotinamide Adenine Dinucleotide)
NA trial testing Oral supplement A in Increase in Blood Levels of Nicotinamide Adenine Dinucleotide (NAD+) in 8 participants. Completed in 24 May 2018.
16 May 2018
Quick facts
| Lead sponsor | Supplement Formulators, Inc. |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | sequential |
| Masking | none |
| Primary purpose | health services research |
| Enrollment | 8 |
| Start date | 12 March 2018 |
| Primary completion | 16 May 2018 |
| Estimated completion | 24 May 2018 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Oral supplement A
- Oral supplement B
- Oral supplement C
- Oral supplement D
- Oral Supplement D in combination with oral supplement C
Conditions studied
- Increase in Blood Levels of Nicotinamide Adenine Dinucleotide (NAD+) — all drugs for Increase in Blood Levels of Nicotinamide Adenine Dinucleotide (NAD+) →
Sponsor
Supplement Formulators, Inc.
Who can join
Adults 30 to 80, any sex, with Increase in Blood Levels of Nicotinamide Adenine Dinucleotide (NAD+). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to assess an effective single oral supplement or combination of oral supplements for increasing whole blood NAD+ levels.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03707652
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Supplement Formulators, Inc. trials
Trials by the same sponsor.
- NCT07371975 — A Study to Evaluate the Effects of a Butyrate-Polyphenol Formulation on Gut Health and Associated Symptoms · NA · recruiting
- NCT06419231 — Effectiveness of a Butyrate Formulation and Butyrate + Polyphenol Formulation on Gut Health, Permeability and Associated · NA · completed
- NCT05854017 — Effects of a Theanine for Stress Relief Formulation in Individuals Who Report Occasional Moderate High Levels of Stress. · NA · active not recruiting
- NCT05450952 — Evaluate the Effects of a Theanine Formulation on Stress, Burnout, Mood, and Sleep in Individuals Who Report Occasional · NA · terminated
- NCT05170113 — Evaluate the Effectiveness and Safety of the Alpinia Galanga Formulation, Theacrine Formulation, and Caffeine Formulatio · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03707652 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Supplement Formulators, Inc.
- Last refreshed: 18 October 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03707652.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing